News No US Remicade biosimilar until at least October Pfizer must wait until 180 day period ends, court fight ongoing.
Clinical Sandoz biosimilar trial hailed as 'landmark' Patients switched between the originator and the near-copy.
News Biosimilars don't need big market share to bring savings - I... Competition can also drive down price of entire drug class.
News US regulatory advisers to review Amgen's Humira biosimilar World's biggest selling drug could face competition.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
